US20090163711A1 - Process of producing amorolfine base - Google Patents

Process of producing amorolfine base Download PDF

Info

Publication number
US20090163711A1
US20090163711A1 US11/795,033 US79503306A US2009163711A1 US 20090163711 A1 US20090163711 A1 US 20090163711A1 US 79503306 A US79503306 A US 79503306A US 2009163711 A1 US2009163711 A1 US 2009163711A1
Authority
US
United States
Prior art keywords
compound
formula
methylbutane
hcl
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/795,033
Inventor
Beat Weber
Stefan Rosenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Assigned to GALDERMA S.A. reassignment GALDERMA S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ROSENBERGER, STEFAN, WEBER, BEAT
Publication of US20090163711A1 publication Critical patent/US20090163711A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms

Definitions

  • the present invention relates to an improved process of producing Amorolfine base, which is an intermediate used in the production of Amorolfine (AMF) hydrochloride (Amorolfine HCl).
  • Amorolfine HCl is an active pharmaceutical ingredient (API) used in topical antimycotic (anti-fungal) compositions.
  • the suggested catalysts are those known for use as Friedel-Crafts catalysts, such as aluminium chloride, iron chloride, lead chloride, zinc chloride, boron trifluoride, hydrogen fluoride, sulphuric acid, and phosphoric acid. Sulfuric acid is stated to be the preferred catalyst.
  • FR 2,463,767 suggests using tertiary alcohols such as 2-methyl-2-butanol, or tertiary chlorides such as 2-chloro-2-methylbutane.
  • 2-methyl-2-butanol is exemplified.
  • the reaction temperature is noted as not being of critical importance but is suggested to be, in general, between 0 and 50° C., preferably between 18 and 20° C.
  • the present invention provides an improved method of producing Amorolfine base, with a higher yield and lower impurity assay resulting.
  • Amorolfine base refers to compounds of formula (I) and the term “bepromoline HCl” refers to compounds of formula (II).
  • 2-halogeno-2-methylbutane refers to 2-methylbutane substituted in position 2 by an halogen atom chosen from the group consisting of bromine, chlorine, iodine, fluorine.
  • the halogen is chlorine and consequently the 2-halogeno-2-methylbutane is 2-chloro-2-methylbutane.
  • the reaction mixture obtained in step (i) may typically be cooled to a temperature between ⁇ 40 to ⁇ 60° C., generally ⁇ 50° C., prior to step (ii), i.e. addition of the 2-halogeno-2-methylbutane.
  • compound of formula (II) is generally present in 1 part of 2-halogeno-2-methylbutane per 1 part compound of formula (II).
  • the process of producing a compound of formula (I) includes, after steps (i) and (ii) above, one or more of the following steps:
  • This process can be performed as described above and can comprise one or more of the steps (a) to (k) above.
  • step of contacting the compound of the formula (III) with the compound of formula (IV) is optionally conducted under basic conditions, with acetic acid added once the consumption of the hydrogen gas has ceased.
  • the basic conditions are generally provided by KOH, typically, 1.8 mol-% KOH.
  • This compound of formula (V) can be obtained from Amorolfine base (compound (I)) thanks to a salification step.
  • a mixture of 1 part of ⁇ -methyl-cinnamaldehyde to one part of cis-2,6-dimethyl-morpholine (DMM) is hydrogenated in methanol in the presence of catalytic amount of palladium on carbon optionally under basic conditions until the up-take of H 2 gas ceases, this indicating completion of the reduction of the C ⁇ C double bond.
  • Acetic acid is then added for the reduction of the C ⁇ N double bond under hydrogen pressure; the C ⁇ N double bond is formed between the aldehyde and the amino moiety of the two reactants, ⁇ -methyl-cinnamaldehyde and DMM, respectively.
  • the catalyst is then filtered off and the methanol is removed by distillation.
  • Toluene is added and the inorganic components are removed by washing with water. Toluene and unreacted DMM are distilled off. Then fresh toluene is added and HCl gas is bubbled through the solution. The pH is adjusted to 3-4. The bepromoline HCl is centrifuged and dried.
  • Methanol might be substituted by toluene to avoid the later solvent exchange step.
  • 40° C. is the optimum temperature for both hydrogenation steps.
  • the temperature may typically be set at no more than 45° C., preferably between 30 and 45° C.
  • the reduction of the C ⁇ N double bond formed between the aldehyde and the amino function of the two components is conducted under hydrogen pressure in acidic conditions after the addition of acetic acid.
  • a molar ratio of acetic acid to KOH is around 1.3 ( ⁇ 10%).
  • the acetic acid is typically added at a temperature range of between 40 to 45° C., and no more than 45° C.
  • the toluene is advantageously added to facilitate the phase separations and the distillation step of the un-reacted DMM, thus improving the purity of bepromoline.
  • trans isomers (VI) and (VII) of bepromoline, coming from trans isomers presents as by products in the 2,6-dimethyl morpholine starting material, are partially eliminated during the crystallization of bepromoline HCl.
  • the purity of the bepromoline HCl (cis isomer) is superior or equal to 99.5%.
  • the product is stable up to 150° C.
  • a reactor was charged with 146 kg ⁇ -methyl-cinnamaldehyde, 115 kg cis-2,6-dimethyl-morpholine, 2.1 kg 50%, KOH, 278 kg methanol and 5.8 kg of a palladium/carbon catalyst and then filled with hydrogen at 15-25° C.
  • the hydrogenation was then run at a pressure of ⁇ 2 bar and 35-45° C. until H 2 consumption ceased.
  • reaction mixture was filtered and the catalyst washed with methanol and purified water
  • the solvents were distilled of at a temperature of up to 95° C. under vacuum.
  • the reactor was charged with 904 kg toluene and 33 kg HCl gas at a temperature of up to 50° C. Then the pH was adjusted to 3-4. The reaction mixture was cooled and then stored under agitation sufficiently to reached complete crystallization.
  • the mixture was centrifuged and washed with cold (0-5° C.) toluene. A second crop of Bepromoline HCl was isolated from the mother liquor.
  • reaction mixture is poured onto an ice-water mixture.
  • the organic phase is separated and washed with acidic water, and then with sodium phosphate solution and with sodium hydroxide solution. After a stripping with toluene, extractions with water are performed. The solvent is then removed. Then the residue is distilled.
  • a suitable molar ratio of FeCl 3 to bepromoline is 1:2 to 1:5 equivalents of catalyst. 1.3 equivalents of FeCl 3 is preferred.
  • the reaction is conducted at low temperature, preferably ⁇ 50° C. (see Table 2):
  • FPM Fenpropimorph
  • the Amorolfine HCl (which is in the DCM) is converted to the free base during these extractions. Phosphate was used to remove traces of Fe.
  • the reactor was charged with 212 kg FeCl 3 and 757 kg DCM. 284 kg bepromoline HCl in 946 kg DCM were added to the reactor at 20-30° C. The reaction mixture was completed with 213 kg DCM and cooled to ⁇ 50° C. 107 kg 2-chloro-2-methylbutane in 107 kg DCM were added at ⁇ 50° C., although a temperature of ⁇ 60 to ⁇ 45° C. is acceptable, and stirred for 2.5 hours. Hydrolysis was performed using 255 kg ice and 785 kg water.
  • Extractions using slightly acidic water (water and diluted HCl) were performed, followed by a further extraction with a solution of Na 3 PO 4 in water.
  • a subsequent extraction was conducted using NaOH diluted in water to a pH ⁇ 13.
  • pH ⁇ 13 At a lower pH value there is incomplete HCl removal, leading to distillation problems.
  • Two washes were performed with water.
  • the solvent was distilled off.
  • the distillation step is necessary to purify Amorolfine Base.
  • AMF base Apart from FPM, all impurities present in AMF base are removed firstly by the salification of AMF base into AMF HCl and secondly by one crystallization step from ethanol.
  • the temperature raises by around 35° C. This exotherm is used to warm the batch. After the addition of HCl the temperature is raised to a level that ensures that the reaction mixture is in solution.
  • the final temperature of ⁇ 20 to ⁇ 15° C. is important to obtain an optimum yield
  • Ethanol is the preferred solvent.
  • the Amorolfine HCl is dissolved in hot ethanol and this solution is filtered to remove foreign matter. The filtrate is then cooled to ⁇ 15 to ⁇ 20° C. to get the optimum yield for crystallization. After centrifugation, the crystals are washed with an appropriate amount of ethanol.
  • the Amorolfine HCl is stable up to 150° C. Drying conditions of 60° C. in a vacuum are used and do not produce any problems with the residual solvent.
  • the reactor was charged with 317 kg AMF and 640 kg ethanol. 38 kg HCl gas was added at 10-65° C. The reaction mixture was then heated to 60° C., followed by cooling to ⁇ 15 to ⁇ 20° C. The mixture was stored for 30 minutes to 2 hours.
  • the Amorolfine HCl was centrifuged and washed with 210 kg of ethanol.
  • the hot solution was filtered and the filter rinsed with 15 kg hot ethanol.
  • the filtrate was then cooled to ⁇ 15 to ⁇ 20° C. and stored for 30 minutes to 2 hours.
  • the crystallized Amorolfine HCl was centrifuged and washed with 210 kg of ethanol.
  • the mixture was then dried at a temperature of 60° C. under vacuum ( ⁇ 100 mbar).

Abstract

An improved process of producing Amorolfine base, which is a compound of formula (I):
Figure US20090163711A1-20090625-C00001
said process including the steps of:
    • (i) contacting a compound of formula (II):
Figure US20090163711A1-20090625-C00002
with a Friedel-Crafts catalyst at a temperature in the range of 20° to 30° C.;
    • (ii) adding a 2-halogeno-2-methylbutane thereto, and wherein the reaction mixture obtained in step (i) is cooled to a temperature of from −40° to −60° C. prior to step (ii).

Description

  • The present invention relates to an improved process of producing Amorolfine base, which is an intermediate used in the production of Amorolfine (AMF) hydrochloride (Amorolfine HCl).
  • Amorolfine HCl is an active pharmaceutical ingredient (API) used in topical antimycotic (anti-fungal) compositions.
  • French Patent Application No 2,463,767 describes methods of producing Amorolfine HCl and intermediates in such production. In particular a method for the production of Amorolfine base (AMF base), which is a compound of formula (I):
  • Figure US20090163711A1-20090625-C00003
  • is described, the method involving the step of reacting a compound of the formula (a):
  • Figure US20090163711A1-20090625-C00004
  • with a compound of the formula (b):
  • Figure US20090163711A1-20090625-C00005
  • in a Friedel-Crafts alkylation to form AMF base. The suggested catalysts are those known for use as Friedel-Crafts catalysts, such as aluminium chloride, iron chloride, lead chloride, zinc chloride, boron trifluoride, hydrogen fluoride, sulphuric acid, and phosphoric acid. Sulfuric acid is stated to be the preferred catalyst. To furnish a compound of the formula (b):
  • Figure US20090163711A1-20090625-C00006
  • FR 2,463,767 suggests using tertiary alcohols such as 2-methyl-2-butanol, or tertiary chlorides such as 2-chloro-2-methylbutane. However, only 2-methyl-2-butanol is exemplified. The reaction temperature is noted as not being of critical importance but is suggested to be, in general, between 0 and 50° C., preferably between 18 and 20° C.
  • There remains a need for improved processes for the production of Amorolfine salts, for example Amorolfine HCl, and its intermediates, such as Amorolfine base.
  • The inventors of the present invention have discovered that significant benefits can be obtained if a tertiary chloride such as 2-chloro-2-methylbutane is added to a compound of the formula (a):
  • Figure US20090163711A1-20090625-C00007
  • in mixture with FeCl3 as Friedel-Craft catalyst at a temperature between −40 to −60° C., preferably around −50° C.
  • The present invention provides an improved method of producing Amorolfine base, with a higher yield and lower impurity assay resulting.
  • According to a first aspect of the invention, there is provided a process of manufacturing a compound of formula (I):
  • Figure US20090163711A1-20090625-C00008
  • said process comprising the steps of:
      • (i) contacting a compound of formula (II):
  • Figure US20090163711A1-20090625-C00009
  • with FeCl3 as Friedel-Crafts catalyst at a temperature in the range of 20 to 30° C.; and
      • (ii) adding one equivalent of 2-halogeno-2-methylbutane,
        characterised in that the reaction mixture obtained in step (i) is cooled to a temperature between −40 to −60° C. prior to step (ii) (addition of the 2-halogeno-2-methylbutane).
  • As used herein the term “Amorolfine base” (AMF base) refers to compounds of formula (I) and the term “bepromoline HCl” refers to compounds of formula (II).
  • As used herein the term “2-halogeno-2-methylbutane” refers to 2-methylbutane substituted in position 2 by an halogen atom chosen from the group consisting of bromine, chlorine, iodine, fluorine.
  • More preferably, the halogen is chlorine and consequently the 2-halogeno-2-methylbutane is 2-chloro-2-methylbutane.
  • The reaction mixture obtained in step (i) may typically be cooled to a temperature between −40 to −60° C., generally −50° C., prior to step (ii), i.e. addition of the 2-halogeno-2-methylbutane.
  • Friedel-Crafts catalyst FeCl3 is generally used in dichloromethane (DCM).
  • Moreover the compound of formula (II) is generally present in 1 part of 2-halogeno-2-methylbutane per 1 part compound of formula (II).
  • In one embodiment, the process of producing a compound of formula (I) includes, after steps (i) and (ii) above, one or more of the following steps:
      • (a) pouring the reaction mixture from step (ii) onto an ice-water mixture;
      • (b) separating the organic phase (i.e. DCM);
      • (c) washing the organic phase with optionally acidified, water,
      • (d) washing the organic phase with water;
      • (e) washing the organic phase from step (d) with a solution of sodium phosphate;
      • (f) washing the organic phase from step (e) with a solution of sodium hydroxide;
      • (g) washing the organic phase from step (f) with water;
      • (h) exchanging the dichloromethane solvent to toluene;
      • (i) performing toluene/water extractions;
      • (j) removing the toluene by distillation; and
      • (k) distilling the crude Amorolfine base from step (j).
  • As the preferred 2-halogeno-2-methylbutane is 2-chloro-2-methylbutane according to present invention, there is provided the preferred process of producing a compound of formula (I):
  • Figure US20090163711A1-20090625-C00010
  • said process comprising the steps of:
      • (i) contacting a compound of formula (II):
  • Figure US20090163711A1-20090625-C00011
  • with FeCl3 as Friedel-Crafts catalyst at a temperature in the range of 20 to 30° C.; and
      • (ii) adding 2-chloro-2-methylbutane, characterised in that the reaction mixture obtained in step (i) is cooled to a temperature between −40 to −60° C. prior to step (ii) (addition of the 2-chloro-2-methylbutane).
  • This process can be performed as described above and can comprise one or more of the steps (a) to (k) above.
  • According to the present invention, the process of producing a compound of formula (I):
  • Figure US20090163711A1-20090625-C00012
  • comprises steps (i) and (ii). Said steps can be preceded by the step of contacting a compound of the formula (III):
  • Figure US20090163711A1-20090625-C00013
  • with a compound of formula (IV):
  • Figure US20090163711A1-20090625-C00014
  • in the presence of a catalyst such as palladium precipitated onto carbon, methanol and hydrogen gas, wherein the step of contacting the compound of the formula (III) with the compound of formula (IV) is optionally conducted under basic conditions, with acetic acid added once the consumption of the hydrogen gas has ceased.
  • Compounds of formulae (III) and (IV) are termed herein “α-methylcinnamaldehyde” and “cis-2,6-dimethyl morpholine” (DMM), respectively.
  • The basic conditions are generally provided by KOH, typically, 1.8 mol-% KOH.
  • According to a second aspect of the present invention, there is provided a process of producing a compound of formula (V):
  • Figure US20090163711A1-20090625-C00015
  • comprising a process as described above for the first aspect of the present invention.
  • This compound of formula (V) can be obtained from Amorolfine base (compound (I)) thanks to a salification step.
  • Typical and usual features of each aspect of the invention are as for each of the other aspects of the invention mutatis mutandis.
  • Throughout the specification, unless the context demands otherwise, the terms “comprise” or “include”, or variations such as “comprising” and “including” will be understood to imply the inclusion of a stated feature, or group of features, but not to the exclusion of any other feature, or group of features.
  • The present invention will now be described by way of example only, with reference to the following examples which are not intended to be limiting on the invention.
  • EXAMPLE 1 Production of Bepromoline HCl a) General Considerations:
  • A mixture of 1 part of α-methyl-cinnamaldehyde to one part of cis-2,6-dimethyl-morpholine (DMM) is hydrogenated in methanol in the presence of catalytic amount of palladium on carbon optionally under basic conditions until the up-take of H2 gas ceases, this indicating completion of the reduction of the C═C double bond. Acetic acid is then added for the reduction of the C═N double bond under hydrogen pressure; the C═N double bond is formed between the aldehyde and the amino moiety of the two reactants, α-methyl-cinnamaldehyde and DMM, respectively.
  • The catalyst is then filtered off and the methanol is removed by distillation. Toluene is added and the inorganic components are removed by washing with water. Toluene and unreacted DMM are distilled off. Then fresh toluene is added and HCl gas is bubbled through the solution. The pH is adjusted to 3-4. The bepromoline HCl is centrifuged and dried.
  • Schematic of Production of Bepromoline HCl:
  • Figure US20090163711A1-20090625-C00016
  • Provision of Basic Conditions
  • Basic conditions were provided by KOH, which is used to neutralise the acidic components present in the α-methyl-cinnamaldehyde. The absence of traces of acid improved the kinetic of the reaction. The reduction of the aldehyde function to the corresponding alcohol is avoided by addition of KOH.
  • Solvent
  • Methanol might be substituted by toluene to avoid the later solvent exchange step.
  • Temperature of Hydrogenation
  • 40° C. is the optimum temperature for both hydrogenation steps. However, the temperature may typically be set at no more than 45° C., preferably between 30 and 45° C.
  • Acetic Acid
  • The reduction of the C═N double bond formed between the aldehyde and the amino function of the two components is conducted under hydrogen pressure in acidic conditions after the addition of acetic acid.
  • A molar ratio of acetic acid to KOH is around 1.3 (±10%).
  • The acetic acid is typically added at a temperature range of between 40 to 45° C., and no more than 45° C.
  • Toluene Exchange
  • The toluene is advantageously added to facilitate the phase separations and the distillation step of the un-reacted DMM, thus improving the purity of bepromoline.
  • Bepromoline.HCl Purity
  • The trans isomers (VI) and (VII) of bepromoline, coming from trans isomers presents as by products in the 2,6-dimethyl morpholine starting material, are partially eliminated during the crystallization of bepromoline HCl.
  • Figure US20090163711A1-20090625-C00017
  • The purity of the bepromoline HCl (cis isomer) is superior or equal to 99.5%.
  • Stability Temperature
  • The product is stable up to 150° C.
  • b) Synthesis:
  • (Weights are given for 1 kmol α-methyl-cinnamaldehyde).
  • A reactor was charged with 146 kg α-methyl-cinnamaldehyde, 115 kg cis-2,6-dimethyl-morpholine, 2.1 kg 50%, KOH, 278 kg methanol and 5.8 kg of a palladium/carbon catalyst and then filled with hydrogen at 15-25° C.
  • The hydrogenation was then run at a pressure of ˜2 bar and 35-45° C. until H2 consumption ceased.
  • 1.5 kg acetic acid was then added, and the hydrogenation was re-commenced. The hydrogenation was conducted at a pressure of ˜2 bar and at a temperature of 40-45° C. until no further H2 was consumed.
  • The reaction mixture was filtered and the catalyst washed with methanol and purified water
  • The solvents were distilled of at a temperature of up to 95° C. under vacuum.
  • Two extractions were performed using toluene and water. The waste water was drained off.
  • The solvent was then distilled off under vacuum.
  • The reactor was charged with 904 kg toluene and 33 kg HCl gas at a temperature of up to 50° C. Then the pH was adjusted to 3-4. The reaction mixture was cooled and then stored under agitation sufficiently to reached complete crystallization.
  • The mixture was centrifuged and washed with cold (0-5° C.) toluene. A second crop of Bepromoline HCl was isolated from the mother liquor.
  • The process yielded 287 kg wet bepromoline HCl, which was then dried at 60° C. under vacuum. After drying, the first crop of Bepromoline HCl was 227 kg and the second 18 kg. This corresponds to a yield of 87%. (80% for the first crop Bepromoline HCl and 7% for the second crop)
  • EXAMPLE 2 Production of Amorolfine Base a) General Considerations:
  • 1 part bepromoline.HCl is treated with 1.3 parts FeCl3±5% in dichloromethane at room temperature. The resulting slurry is cooled to approximately −50° C., whereupon 1 to 1.1 parts of 2-chloro-2-methylbutane is added.
  • After an appropriate reaction time of around 2.5 hours, the reaction mixture is poured onto an ice-water mixture. The organic phase is separated and washed with acidic water, and then with sodium phosphate solution and with sodium hydroxide solution. After a stripping with toluene, extractions with water are performed. The solvent is then removed. Then the residue is distilled.
  • Schematic of Production of Amorolfine Base:
  • Figure US20090163711A1-20090625-C00018
  • Reaction Temperature for the Addition of FeCl3 to Bepromoline HCl
  • The addition of FeCl3 to Bepromoline HCl takes place at room temperature. At lower temperatures the subsequent Friedel-Crafts alkylation fails partially or completely (Table 1)
  • TABLE 1
    Bepromoline assay in the
    Temperature (° C.) crude Amorolfine base (%)
    20-30 8-14
    0 14
    −20 100
  • Friedel-Crafts Catalysts
  • A suitable molar ratio of FeCl3 to bepromoline is 1:2 to 1:5 equivalents of catalyst. 1.3 equivalents of FeCl3 is preferred.
  • Reaction Temperature for Friedel-Crafts Alkylation
  • To decrease the fenpropimorph (FPM) by-product, the reaction is conducted at low temperature, preferably −50° C. (see Table 2):
  • TABLE 2
    Figure US20090163711A1-20090625-C00019
    Fenpoprimorph (FPM)
    Temperature (° C.) FPM (%)
    −52 to −49 0.14-0.25
    −40 1.7
    −35 2.0
    −20 2.7
  • Fenpropimorph (FPM) is a problematic by-product as it is difficult to remove from the end product.
  • Ratio of Bepromoline HCl to 2-chloro-2-methylbutane
  • Batches were performed with 10% excess 2-chloro-2-methylbutane, and at a 1:1 ratio. The FPM assay is lower for the 1:1 ratio and thus this proportion is preferred.
  • Phosphate and Alkaline Extraction
  • The Amorolfine HCl (which is in the DCM) is converted to the free base during these extractions. Phosphate was used to remove traces of Fe.
  • Solvent Exchange
  • Advantages result if the solvents are exchanged (i.e. toluene in place of DCM): the volume is reduced and the waste-water is contaminated with less chlorinated solvent.
  • Toluene-Water Extraction
  • Those extractions are necessary to get the appropriate quality for the subsequent distillation. If these extractions are omitted, the Amorolfine base slightly decomposes at 180° C. The distillation become very sluggish and fumes are formed. The vacuum distillation is then not possible at plant scale.
  • The yield was approximately 90% of crude Amorolfine base.
  • b) Synthesis:
  • (weights are given for 1 kmol bepromoline HCl)
  • The reactor was charged with 212 kg FeCl3 and 757 kg DCM. 284 kg bepromoline HCl in 946 kg DCM were added to the reactor at 20-30° C. The reaction mixture was completed with 213 kg DCM and cooled to −50° C. 107 kg 2-chloro-2-methylbutane in 107 kg DCM were added at −50° C., although a temperature of −60 to −45° C. is acceptable, and stirred for 2.5 hours. Hydrolysis was performed using 255 kg ice and 785 kg water.
  • Phase separation was then performed.
  • Extractions using slightly acidic water (water and diluted HCl) were performed, followed by a further extraction with a solution of Na3PO4 in water. A subsequent extraction was conducted using NaOH diluted in water to a pH≧13. At a lower pH value there is incomplete HCl removal, leading to distillation problems. Two washes were performed with water.
  • The solvent was distilled off.
  • Toluene was added and four water extractions were performed. Finally the solvent was distilled off under vacuum.
  • This yielded 283 kg crude AMF (approximately 90% AMF base crude).
  • EXAMPLE 3 Distillation of Amorolfine Base
  • a) General Considerations:
  • The distillation step is necessary to purify Amorolfine Base.
  • Schematic of the Distillation Process:
  • Figure US20090163711A1-20090625-C00020
  • b) Distillation:
  • 283 kg of crude Amorolfine base are distilled at 141°-144° C. under reduced pressure (typically 0.14-0.15 mbar). The fractions are combined in such a way that the impurity profile of the combined material is within the desired specification.
  • After distillation, 190 kg AMF base were produced (approximately 67% AMF base distilled).
  • EXAMPLE 4 Production of Amorolfine HCl and Evaluation of the Purity of the Produced Compound
  • a) General Considerations:
  • i) purpose: The aim of this stage is to ensure that sufficient impurities are properly removed with the formation of the Amorolfine HCl and only one crystallisation step with ethanol being used.
  • ii) production of Amorolfine HCl with Amorolfine base (salification step): HCl gas is added to a solution of Amorolfine base in two parts of ethanol until the pH reaches 1.5 to 3. The Amorolfine HCl crystallises at around 45° C. The slurry is cooled to no less than −15° C. (which should take no less than 2 hours). The crude Amorolfine HCl is isolated by centrifugation and washed with cold ethanol. The crude Amorolfine HCl is then re-crystallised at between −20 to −15° C. from two parts of ethanol.
  • Schematic of the Process
  • Figure US20090163711A1-20090625-C00021
  • Amounts of by-Products in the Amorolfine Base
  • Apart from FPM, all impurities present in AMF base are removed firstly by the salification of AMF base into AMF HCl and secondly by one crystallization step from ethanol.
  • The data given in Table 3 were taken from different crystallizations experiments.
  • TABLE 3
    Bepromoline FPM Trans-isomers
    (%) (%) (%)
    AMF base 5 0.25 0.5
    AMF HCl crude 0.3 0.25 0.3
    AMF HCl <0.1 0.25 <0.2
    Required spec. <0.2 <0.3 <0.2
  • Reaction Temperature
  • During the addition of the HCl gas, the temperature raises by around 35° C. This exotherm is used to warm the batch. After the addition of HCl the temperature is raised to a level that ensures that the reaction mixture is in solution.
  • The final temperature of −20 to −15° C. is important to obtain an optimum yield
  • Re-Crystallisation of the Amorolfine HCl
  • Ethanol is the preferred solvent. The Amorolfine HCl is dissolved in hot ethanol and this solution is filtered to remove foreign matter. The filtrate is then cooled to −15 to −20° C. to get the optimum yield for crystallization. After centrifugation, the crystals are washed with an appropriate amount of ethanol.
  • Drying
  • The Amorolfine HCl is stable up to 150° C. Drying conditions of 60° C. in a vacuum are used and do not produce any problems with the residual solvent.
  • b) Synthesis:
  • (Weights are given for 1 kmol AMF base)
  • The reactor was charged with 317 kg AMF and 640 kg ethanol. 38 kg HCl gas was added at 10-65° C. The reaction mixture was then heated to 60° C., followed by cooling to −15 to −20° C. The mixture was stored for 30 minutes to 2 hours.
  • The Amorolfine HCl was centrifuged and washed with 210 kg of ethanol.
  • 2 parts ethanol were used to dissolve the Amorolfine HCl at 70-80° C.
  • The hot solution was filtered and the filter rinsed with 15 kg hot ethanol. The filtrate was then cooled to −15 to −20° C. and stored for 30 minutes to 2 hours.
  • The crystallized Amorolfine HCl was centrifuged and washed with 210 kg of ethanol.
  • The mixture was then dried at a temperature of 60° C. under vacuum (<100 mbar).
  • This yielded 271 kg AMF HCl. The yield was approximately 77%
  • Various modifications and variations to the described embodiments of the inventions will be apparent to those skilled in the art without departing from the scope of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes of carrying out the invention which are obvious to those skilled in the art are intended to be covered by the present invention.

Claims (9)

1.-7. (canceled)
8. A process of producing a compound of formula (I):
Figure US20090163711A1-20090625-C00022
said process comprising the steps of:
(i) contacting a compound of formula (II):
Figure US20090163711A1-20090625-C00023
with a FeCl3 Friedel-Crafts catalyst at a temperature in the range of 20° to 30° C.; and
(ii) adding a 2-halogeno-2-methylbutane thereto, and wherein the reaction mixture obtained in step (i) is cooled to a temperature of from −400 to −60° C. prior to step (ii).
9. The process as defined by claim 1, wherein the reaction mixture obtained in step (i) is cooled to a temperature of about −50° C. prior to step (ii).
10. The process as defined by claim 1, wherein the Friedel-Crafts catalyst FeCl3 is employed in dichloromethane.
11. The process as defined by claim 1, wherein the compound of formula (II) is present in 1 part of 2-halogeno-2-methylbutane per 1 part of the compound of formula (II).
12. The process as defined by claim 1, further comprising one or more of the following steps:
(a) pouring the reaction mixture from step (ii) onto an ice-water mixture;
(b) separating the organic phase (i.e., DCM);
(c) washing the organic phase with optionally acidified water;
(d) washing the organic phase with water;
(e) washing the organic phase from step (d) with a solution of sodium phosphate;
(f) washing the organic phase from step (e) with a solution of sodium hydroxide;
(g) washing the organic phase from step (f) with water;
(h) exchanging the dichloromethane solvent to toluene;
(i) performing toluene/water extractions;
(j) removing the toluene by distillation; and
(k) distilling the crude Amorolfine base from step (j).
13. The process as defined by claim 1, wherein said 2-halogeno-2-methylbutane is 2-chloro-2-methylbutane.
14. A process of producing a compound of formula (V):
Figure US20090163711A1-20090625-C00024
comprising conducting the process as defined by claim 1 to obtain the compound of formula (I), and thence conducting a salification of the compound of formula (I).
15. The process as defined by claim 1, comprising adding one equivalent of said 2-halogeno-2-methylbutane.
US11/795,033 2005-07-28 2006-07-27 Process of producing amorolfine base Abandoned US20090163711A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05291612A EP1749825A1 (en) 2005-07-28 2005-07-28 Process of producing amorolfine
EP05291612.9 2005-07-28
PCT/IB2006/003210 WO2007012983A2 (en) 2005-07-28 2006-07-27 Process of producing amorolfine

Publications (1)

Publication Number Publication Date
US20090163711A1 true US20090163711A1 (en) 2009-06-25

Family

ID=35044548

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/795,033 Abandoned US20090163711A1 (en) 2005-07-28 2006-07-27 Process of producing amorolfine base

Country Status (15)

Country Link
US (1) US20090163711A1 (en)
EP (2) EP1749825A1 (en)
JP (1) JP2009502901A (en)
AR (1) AR057087A1 (en)
AT (1) ATE417839T1 (en)
BR (1) BRPI0606197B8 (en)
CA (1) CA2601149C (en)
CY (1) CY1108884T1 (en)
DE (1) DE602006004360D1 (en)
DK (1) DK1917254T3 (en)
ES (1) ES2319819T3 (en)
PL (1) PL1917254T3 (en)
PT (1) PT1917254E (en)
SI (1) SI1917254T1 (en)
WO (1) WO2007012983A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232458A (en) * 2018-06-15 2019-01-18 南通常佑药业科技有限公司 A kind of preparation method of chirality morpholinium compound

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1935889A1 (en) * 2006-12-21 2008-06-25 Galderma S.A. Process of producing amorolfine
SG171954A1 (en) 2008-12-04 2011-07-28 Hoffmann La Roche Pyridazinone derivatives
ITFI20090032A1 (en) 2009-02-20 2010-08-21 Synteco S P A Prodotti Di Sintesi Per L Ind INDUSTRIAL PRODUCTION PROCESS OF CHLORIDATED AMOROLFIN
WO2011003455A1 (en) * 2009-07-09 2011-01-13 Cilag Ag Method for producing 4-(alkyl)-1-(2-methyl-3-(2,6-dimethylmorpholine)propyl) benzol compounds
WO2011066735A1 (en) * 2009-12-01 2011-06-09 Zhejiang Hisoar Pharmaceutical Co., Ltd An Amorolfine HCl Crystal and the Preparation thereof
CN108997246B (en) * 2017-06-06 2021-08-31 江苏礼华生物技术有限公司 Preparation method of amorolfine hydrochloride

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384116A (en) * 1978-08-08 1983-05-17 Hoffmann-La Roche Inc. Process for the preparation of morpholine and piperidine derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW15780A1 (en) * 1979-08-17 1981-03-18 Hoffmann La Roche Heterocyclic compounds
FR2589858A1 (en) * 1985-11-14 1987-05-15 Exxon Production Research Co Process for selective alkylation of aromatic compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384116A (en) * 1978-08-08 1983-05-17 Hoffmann-La Roche Inc. Process for the preparation of morpholine and piperidine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109232458A (en) * 2018-06-15 2019-01-18 南通常佑药业科技有限公司 A kind of preparation method of chirality morpholinium compound

Also Published As

Publication number Publication date
EP1749825A1 (en) 2007-02-07
WO2007012983A3 (en) 2007-05-03
CY1108884T1 (en) 2014-07-02
AR057087A1 (en) 2007-11-14
BRPI0606197B1 (en) 2021-03-30
DE602006004360D1 (en) 2009-01-29
DK1917254T3 (en) 2009-03-16
WO2007012983A2 (en) 2007-02-01
EP1917254A2 (en) 2008-05-07
EP1917254B1 (en) 2008-12-17
CA2601149A1 (en) 2007-02-01
ES2319819T3 (en) 2009-05-12
CA2601149C (en) 2011-01-04
SI1917254T1 (en) 2009-04-30
ATE417839T1 (en) 2009-01-15
BRPI0606197B8 (en) 2021-05-25
PL1917254T3 (en) 2009-06-30
JP2009502901A (en) 2009-01-29
PT1917254E (en) 2009-02-23
BRPI0606197A2 (en) 2009-06-02

Similar Documents

Publication Publication Date Title
US20090163711A1 (en) Process of producing amorolfine base
US8207354B2 (en) Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates
US8242268B2 (en) Production of bepromoline
US8049007B2 (en) Preparation of amorolfine
JP2002544184A (en) (1R, 2S, 4R)-(-)-2-[(2 &#39;-{N, N-dimethylamino} -ethoxy)]-2- [phenyl] -1,7,7-tri- [methyl]- Process for producing bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
US6262308B1 (en) Process for the preparation of racemic sertraline
EP1673365B1 (en) Process for the preparation of z-flupentixol
US7470816B2 (en) Tramadol recovery process
US11518733B2 (en) Process for preparation of highly pure Fingolimod hydrochloride
JP2506376B2 (en) Method for producing 2- (4-methylaminobutoxy) diphenylmethane hydrochloride
US7034158B2 (en) Method of producing biperiden I
US20240018096A1 (en) Industrial process for the preparation of hexanoic acid, 6-(nitrooxy)-, (1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester and high pure product
WO2011150950A1 (en) 2-methyl-5-vinylpyridinium salts
JPH06329655A (en) Production of polyalkyl-2-alkoxy-7-hydroxychroman
JPH04145052A (en) Production of n-alkyl-n-hydroxylalkylanilines
JPS62132858A (en) Production of 2,2,6,6-tetramethyl-4-oxopiperidine

Legal Events

Date Code Title Description
AS Assignment

Owner name: GALDERMA S.A.,SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WEBER, BEAT;ROSENBERGER, STEFAN;SIGNING DATES FROM 20090128 TO 20090207;REEL/FRAME:022358/0409

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION